Since aberrant DNA methylation as a marker of platinum-resistance was shown in lung and ovarian cancer cell lines [26, 27]; we examined the methylation status of GTSE1 in gastric cancer patients who underwent neoadjuvant DCX-combinational chemo therapy. Here, GTSE1 is linked to ovarian carcinoma.